Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 118

1.

Towards Effective Cost-Effectiveness Analysis in Atherosclerotic Cardiovascular Disease Prevention.

Kajinami K.

Circ J. 2018 Mar 23;82(4):954-955. doi: 10.1253/circj.CJ-18-0193. Epub 2018 Mar 10. No abstract available.

2.

Treatment Patterns, Statin Intolerance, and Subsequent Cardiovascular Events Among Japanese Patients With High Cardiovascular Risk Initiating Statin Therapy.

Nagar SP, Rane PP, Fox KM, Meyers J, Davis K, Beaubrun A, Inomata H, Qian Y, Kajinami K.

Circ J. 2018 Mar 23;82(4):1008-1016. doi: 10.1253/circj.CJ-17-0811. Epub 2017 Dec 23.

3.

Circulating malondialdehyde-modified low-density lipoprotein (MDA-LDL) as a novel predictor of clinical outcome after endovascular therapy in patients with peripheral artery disease (PAD).

Takamura TA, Tsuchiya T, Oda M, Watanabe M, Saito R, Sato-Ishida R, Akao H, Kawai Y, Kitayama M, Kajinami K.

Atherosclerosis. 2017 Aug;263:192-197. doi: 10.1016/j.atherosclerosis.2017.06.029. Epub 2017 Jun 16.

PMID:
28651186
4.

Efficacy and Safety of an Orally Administered Selective Prostacyclin Receptor Agonist, Selexipag, in Japanese Patients With Pulmonary Arterial Hypertension.

Tanabe N, Ikeda S, Tahara N, Fukuda K, Hatano M, Ito H, Nakayama T, Anzai T, Hashimoto A, Inoue T, Kajinami K, Kihara Y, Kinoshita H, Kuwahara K, Murohara T, Okazaki O, Sakai S, Satoh T, Takeda Y, Takeishi Y, Taniguchi M, Watanabe H, Yamamoto T, Yamauchi-Takihara K, Yoshioka K, Sasayama S.

Circ J. 2017 Aug 25;81(9):1360-1367. doi: 10.1253/circj.CJ-16-1348. Epub 2017 Apr 18.

5.

A possible role for HLA-DRB1*04:06 in statin-related myopathy in Japanese patients.

Sai K, Kajinami K, Akao H, Iwadare M, Sato-Ishida R, Kawai Y, Takeda K, Tanimoto T, Yamano T, Akasaka T, Ishida T, Hirata KI, Saku K, Yagi S, Soeki T, Sata M, Ueno M, Miyazaki S, Shiraki A, Oyama JI, Node K, Sugamura K, Ogawa H, Kurose K, Maekawa K, Matsuzawa Y, Imatoh T, Hasegawa R; Japanese Pharmacogenomics Data Science Consortium, Saito Y.

Drug Metab Pharmacokinet. 2016 Dec;31(6):467-470. doi: 10.1016/j.dmpk.2016.09.002. Epub 2016 Sep 17.

PMID:
27839692
6.

Clinical impact and risk stratification of balloon angioplasty for femoropopliteal disease in nitinol stenting era: Retrospective multicenter study using propensity score matching analysis.

Tsuchiya T, Takamura T, Soga Y, Iida O, Hirano K, Suzuki K, Yamaoka T, Miyashita Y, Kitayama M, Kajinami K.

SAGE Open Med. 2016 Jul 18;4:2050312116660116. doi: 10.1177/2050312116660116. eCollection 2016.

7.

Diurnal glycemic fluctuation is associated with severity of coronary artery disease in prediabetic patients: Possible role of nitrotyrosine and glyceraldehyde-derived advanced glycation end products.

Watanabe M, Kawai Y, Kitayama M, Akao H, Motoyama A, Wakasa M, Saito R, Aoki H, Fujibayashi K, Tsuchiya T, Nakanishi H, Saito K, Takeuchi M, Kajinami K.

J Cardiol. 2017 Apr;69(4):625-631. doi: 10.1016/j.jjcc.2016.07.001. Epub 2016 Jul 26.

8.

18F-FDG PET/CT for Detecting Sarcoma of the Aorta in a Patient with Takayasu Arteritis.

Takahashi T, Watanabe N, Wakasa M, Kajinami K, Tonami H.

Nucl Med Mol Imaging. 2016 Jun;50(2):171-2. doi: 10.1007/s13139-015-0347-z. Epub 2015 Jun 30. No abstract available.

9.

Prediction of all-cause death using (11)C-hydroxyephedrine positron emission tomography in Japanese patients with left ventricular dysfunction.

Fujita W, Matsunari I, Aoki H, Nekolla SG, Kajinami K.

Ann Nucl Med. 2016 Aug;30(7):461-7. doi: 10.1007/s12149-016-1081-z. Epub 2016 May 18.

10.

Circulating Glutamate and Taurine Levels Are Associated with the Generation of Reactive Oxygen Species in Paroxysmal Atrial Fibrillation.

Takano S, Fujibayashi K, Fujioka N, Ueno E, Wakasa M, Kawai Y, Kajinami K.

Dis Markers. 2016;2016:7650976. doi: 10.1155/2016/7650976. Epub 2016 Jan 6.

11.

Clinical characteristics of patients with Rutherford category IV, compared with V and VI.

Tsuchiya T, Iida O, Shiraki T, Soga Y, Hirano K, Suzuki K, Yamaoka T, Miyashita Y, Kitayama M, Kajinami K.

SAGE Open Med. 2015 Jul 22;3:2050312115597087. doi: 10.1177/2050312115597087. eCollection 2015.

12.

Lipoprotein(a): Revisiting a Next Therapeutic Target.

Kajinami K.

Circ J. 2016;80(2):329-31. doi: 10.1253/circj.CJ-15-1381. Epub 2016 Jan 12. No abstract available.

13.

A case of coronary rupture and pseudoaneurysm formation after fracture of implanted paclitaxel-eluting stents.

Kawai Y, Kitayama M, Akao H, Motoyama A, Tsuchiya T, Kajinami K.

Cardiovasc Interv Ther. 2016 Jul;31(3):231-7. doi: 10.1007/s12928-015-0338-0. Epub 2015 May 22.

PMID:
25998891
14.

[Report from the 40th Hokuriku Chapter Educational Seminar: overview and evaluation results of the second abdominal emergency medical training course (AbdEMeT)].

Mihara H, Okazawa S, Wada A, Matsui S, Kajinami K.

Nihon Naika Gakkai Zasshi. 2014 Apr 10;103(4):983-6. Japanese. No abstract available.

PMID:
24908998
15.

ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment.

Akao H, Polisecki E, Schaefer EJ, Trompet S, Robertson M, Ford I, Jukema JW, de Craen AJ, Packard C, Buckley BM, Kajinami K; PROspective Study of Pravastatin in the Elderly at Risk Investigator.

Atherosclerosis. 2014 Jul;235(1):176-81. doi: 10.1016/j.atherosclerosis.2014.04.030. Epub 2014 May 8.

16.

Increased levels of the oxidative stress marker, nitrotyrosine in patients with provocation test-induced coronary vasospasm.

Tanabe K, Kawai Y, Kitayama M, Akao H, Ishida R, Motoyama A, Wakasa M, Saito R, Aoki H, Fujibayashi K, Watanabe M, Tsuchiya T, Kimura H, Yoshida K, Kajinami K.

J Cardiol. 2014 Aug;64(2):86-90. doi: 10.1016/j.jjcc.2013.11.017. Epub 2014 Jan 4.

17.

Nutri-pharmacogenomics of warfarin anticoagulation therapy: VKORC1 genotype-dependent influence of dietary vitamin K intake.

Saito R, Takeda K, Yamamoto K, Nakagawa A, Aoki H, Fujibayashi K, Wakasa M, Motoyama A, Iwadare M, Ishida R, Fujioka N, Tsuchiya T, Akao H, Kawai Y, Kitayama M, Kajinami K.

J Thromb Thrombolysis. 2014 Jul;38(1):105-14. doi: 10.1007/s11239-013-0978-9.

PMID:
23928870
18.

Management and two-year long-term clinical outcome of acute coronary syndrome in Japan: prevention of atherothrombotic incidents following ischemic coronary attack (PACIFIC) registry.

Daida H, Miyauchi K, Ogawa H, Yokoi H, Matsumoto M, Kitakaze M, Kimura T, Matsubara T, Ikari Y, Kimura K, Tsukahara K, Origasa H, Morino Y, Tsutsui H, Kobayashi M, Isshiki T; PACIFIC investigators.

Circ J. 2013;77(4):934-43. Epub 2013 Mar 15.

19.

Myocardial sympathetic innervation, function, and oxidative metabolism in non-infarcted myocardium in patients with prior myocardial infarction.

Aoki H, Matsunari I, Nomura Y, Fujita W, Komatsu R, Miyazaki Y, Nekolla SG, Kajinami K.

Ann Nucl Med. 2013 Jul;27(6):523-31. doi: 10.1007/s12149-013-0716-6. Epub 2013 Mar 14.

PMID:
23494212
20.

Chk1-mediated phosphorylation of receptor-associated late transducer at serine 250 increases its stability by stimulating its interaction with 14-3-3.

Takeda K, Takata T, Kawai Y, Ishigaki Y, Kajinami K.

Genes Cells. 2013 May;18(5):369-86. doi: 10.1111/gtc.12043. Epub 2013 Feb 22.

Supplemental Content

Loading ...
Support Center